Skip to main content
Top
Published in: Neuroradiology 8/2019

01-08-2019 | Glioblastoma | Diagnostic Neuroradiology

Correlation of post-contrast T1-weighted MRI surface regularity, tumor bulk, and necrotic volume with Ki67 and p53 in glioblastomas

Authors: Adam Hasse, Mark Dapash, Yong Jeong, Sameer A. Ansari, Timothy J. Carroll, Maciej Lesniak, Daniel Thomas Ginat

Published in: Neuroradiology | Issue 8/2019

Login to get access

Abstract

Purpose

p53 and Ki67 status can be relevant to the management of glioblastoma. The goal of this study is to determine whether tumor morphology and bulk depicted on MRI correlate with p53 and Ki67 in glioblastoma.

Methods

A retrospective review of 223 patients with glioblastoma and corresponding p53 or Ki67 status, along with T1-weighted post-contrast MR images was performed. Enhancing tumors were outlined for determining surface regularity, tumor bulk, and necrotic volume. The median value of 0.1 was chosen for p53 and 0.2 for Ki67 to separate each data set into two classes. T tests and receiver operating characteristic analysis were performed to determine the separation of the classes and the predicting power of each feature.

Results

There were significant differences between tumor surface regularity (p = 0.01) and necrotic volume (p = 0.0429) according to Ki67 levels, although neither had statistically significant predictive power (AUC = 0.697, p = 0.0506 and AUC = 0.577, p = 0.164, respectively). There were also significant differences between tumor bulk (p = 0.0239) and necrotic volume (p = 0.0200) according to p53 levels, but again no significant predictive power was found using ROC analysis (AUC = 0.5882, p = 0.0894 and AUC = 0.567, p = 0.155, respectively).

Conclusion

Quantitative morphological tumor characteristics on post-contrast T1-weighted MRI can to a certain degree provide insights regarding Ki67 and p53 status in patients with glioblastoma.
Literature
2.
go back to reference Touat M, Idbaih A, Sanson M, Ligon KL (2017) Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol 28:1457–1472CrossRefPubMedPubMedCentral Touat M, Idbaih A, Sanson M, Ligon KL (2017) Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann Oncol 28:1457–1472CrossRefPubMedPubMedCentral
3.
go back to reference Bosnyák E, Michelhaugh SK, Klinger NV, Kamson DO, Barger GR, Mittal S, Juhász C (2017) Prognostic molecular and imaging biomarkers in primary glioblastoma. Clin Nucl Med 42:341–347CrossRefPubMedPubMedCentral Bosnyák E, Michelhaugh SK, Klinger NV, Kamson DO, Barger GR, Mittal S, Juhász C (2017) Prognostic molecular and imaging biomarkers in primary glioblastoma. Clin Nucl Med 42:341–347CrossRefPubMedPubMedCentral
4.
go back to reference Zhang Y, Dube C, Gibert M Jr (2018) The p53 pathway in glioblastoma. Cancers (Basel)10 pii: E297 Zhang Y, Dube C, Gibert M Jr (2018) The p53 pathway in glioblastoma. Cancers (Basel)10 pii: E297
5.
go back to reference England B, Huang T, Karsy M (2013) Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme. Tumour Biol 34:2063–2074CrossRefPubMed England B, Huang T, Karsy M (2013) Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme. Tumour Biol 34:2063–2074CrossRefPubMed
6.
go back to reference Schröder R, Feisel KD, Ernestus RI (2002) Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas. J Neuro-Oncol 56:127–132CrossRef Schröder R, Feisel KD, Ernestus RI (2002) Ki-67 labeling is correlated with the time to recurrence in primary glioblastomas. J Neuro-Oncol 56:127–132CrossRef
7.
go back to reference de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96:1504–1513CrossRefPubMedPubMedCentral de Azambuja E, Cardoso F, de Castro G, Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D, Piccart-Gebhart MJ, Paesmans M (2007) Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer 96:1504–1513CrossRefPubMedPubMedCentral
8.
go back to reference Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, Fernández-Romero A, Luque B, Arregui E, Calvo M, Borrás JM, Meléndez B, Rodríguez de Lope Á, Moreno de la Presa R, Iglesias Bayo L, Barcia JA, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Revert A, Arana E, Pérez-García VM (2018) Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology 288:218–225CrossRefPubMed Pérez-Beteta J, Molina-García D, Ortiz-Alhambra JA, Fernández-Romero A, Luque B, Arregui E, Calvo M, Borrás JM, Meléndez B, Rodríguez de Lope Á, Moreno de la Presa R, Iglesias Bayo L, Barcia JA, Martino J, Velásquez C, Asenjo B, Benavides M, Herruzo I, Revert A, Arana E, Pérez-García VM (2018) Tumor surface regularity at MR imaging predicts survival and response to surgery in patients with glioblastoma. Radiology 288:218–225CrossRefPubMed
9.
go back to reference Grossmann P, Gutman DA, Dunn WD Jr, Holder CA, Aerts HJ (2016) Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in glioblastoma. cBMC Cancer 16:611CrossRef Grossmann P, Gutman DA, Dunn WD Jr, Holder CA, Aerts HJ (2016) Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in glioblastoma. cBMC Cancer 16:611CrossRef
10.
go back to reference Dechristé G, Fehrenbach J, Griseti E, Lobjois V, Poignard C (2018) Viscoelastic modeling of the fusion of multicellular tumor spheroids in growth phase. J Theor Biol 454:102–109CrossRefPubMed Dechristé G, Fehrenbach J, Griseti E, Lobjois V, Poignard C (2018) Viscoelastic modeling of the fusion of multicellular tumor spheroids in growth phase. J Theor Biol 454:102–109CrossRefPubMed
11.
go back to reference Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Cancer Genome Atlas Research Network (2010) An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell 17:98–110CrossRefPubMedPubMedCentral Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN, Cancer Genome Atlas Research Network (2010) An integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1. Cancer Cell 17:98–110CrossRefPubMedPubMedCentral
12.
go back to reference Balogh GA, Mailo D, Nardi H et al (2010) Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients. Exp Ther Med 1:357–361CrossRefPubMedPubMedCentral Balogh GA, Mailo D, Nardi H et al (2010) Serological levels of mutated p53 protein are highly detected at early stages in breast cancer patients. Exp Ther Med 1:357–361CrossRefPubMedPubMedCentral
13.
go back to reference Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neuro-Oncol 27:65–73CrossRef Hammoud MA, Sawaya R, Shi W, Thall PF, Leeds NE (1996) Prognostic significance of preoperative MRI scans in glioblastoma multiforme. J Neuro-Oncol 27:65–73CrossRef
14.
go back to reference Rios Velazquez E, Meier R, Dunn WD Jr et al (2015) Fully automatic GBM segmentation in the TCGA-GBM dataset: prognosis and correlation with VASARI features. Sci Rep 5:16822CrossRefPubMedPubMedCentral Rios Velazquez E, Meier R, Dunn WD Jr et al (2015) Fully automatic GBM segmentation in the TCGA-GBM dataset: prognosis and correlation with VASARI features. Sci Rep 5:16822CrossRefPubMedPubMedCentral
Metadata
Title
Correlation of post-contrast T1-weighted MRI surface regularity, tumor bulk, and necrotic volume with Ki67 and p53 in glioblastomas
Authors
Adam Hasse
Mark Dapash
Yong Jeong
Sameer A. Ansari
Timothy J. Carroll
Maciej Lesniak
Daniel Thomas Ginat
Publication date
01-08-2019
Publisher
Springer Berlin Heidelberg
Published in
Neuroradiology / Issue 8/2019
Print ISSN: 0028-3940
Electronic ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-019-02204-1

Other articles of this Issue 8/2019

Neuroradiology 8/2019 Go to the issue